Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Disseminated fungal infection with in acute myeloid leukemia patient: a case report from a developing country.
Oxf Med Case Reports
January 2025
Infection Control Department, An-Najah National University Hospital, Nablus 44839, West Bank, Palestine.
Background: may cause fatal infections in immunocompromised patients. This is the first case report of invasive infection at an academic-tertiary care center in Palestine.
Case Presentation: We report a 36-year-old woman who presented with fever and severe neutropenia and was found to have AML/Non M3.
A case of kerion celsi caused by with dermatophytid reaction mimicking a drug eruption and endothrix infection confirmed in pathological tissue.
Med Mycol Case Rep
March 2025
Department of Dermatology, Tenri Hospital, 200 Mishima, Tenri, Nara, 632-8552, Japan.
We report a case of kerion celsi caused by in a teenage male judo athlete, presenting with a lesion in the occipital region. Following the initiation of systemic antifungal therapy, the patient developed a dermatophytid reaction, necessitating differentiation from a drug eruption. Direct microscopy of the affected area confirmed the presence of fungal elements, and histopathological examination revealed endothrix invasion, supporting the continuation of treatment.
View Article and Find Full Text PDF[Aspergilosis invasiva con compromiso óseo en lactante de cuatro meses con enfermedad granulomatosa crónica].
Biomedica
December 2024
Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México.
La enfermedad granulomatosa crónica es el error innato de la inmunidad que se acompaña con mayor frecuencia de aspergilosis invasiva. En esta enfermedad, la aspergilosis invasiva se presenta en la adolescencia y es rara antes del año de vida. Se presenta el caso de un infante con enfermedad granulomatosa crónica y aspergilosis invasiva.
View Article and Find Full Text PDFAntifungal potential of silver nanoparticles stabilized with the flavonoid naringenin.
J Med Microbiol
January 2025
Medical Mycology Laboratory, Department of Clinical Analysis and Biomedicine, State University of Maring, Colombo Avenue, 5790, Maring, PR, Brazil.
Fungal infections caused by yeast have increased in recent decades, becoming a major threat to public health. Antifungal therapy represents a challenging problem because, in addition to presenting many side effects, fungal resistance has been increasing in recent years. As a result, the search for new therapeutic agents has advanced with the use of new technologies such as nanoparticles (NPs).
View Article and Find Full Text PDFThe cardiometabolic safety of dupilumab in atopic dermatitis: A global large-scale cohort study.
Arch Dermatol Res
January 2025
Lűbeck Institute of Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.
Background: A low risk of cardiovascular and metabolic outcomes was found in the randomized clinical trials of dupilumab in atopic dermatitis (AD). Dupilumab-associated real-life long-term cardiometabolic risk relative to other systemic agents is yet to be precisely investigated.
Objective: To assess the risk of cardiometabolic outcomes in patients with AD treated with dupilumab relative to those treated with methotrexate and cyclosporine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!